Eli Lilly Product Research
The following is product research of Eli Lilly’s Emgality and Mounjaro products. This research is based on a proprietary data set I collected over a 160+ week period from February 2021-April 2024. I am a chronic migraine patient and have been an analyst for 14 years. The data collection and analysis is my own. Within the data, two trends emerged. First, temporal trends related to the source and triggers of migraines. Second, the treatment effectiveness of Eli Lilly’s Emgality and Mounjaro products increased over time.
The following is product research of Eli Lilly’s Emgality and Mounjaro products. This research is based on a proprietary data set I collected over a 160+ week period from February 2021-April 2024. I am a chronic migraine patient and have been an analyst for 14 years. The data collection and analysis is my own. Within the data, two trends emerged. First, temporal trends related to the source and triggers of migraines. Second, the treatment effectiveness of Eli Lilly’s Emgality and Mounjaro products increased over time.
The following is product research of Eli Lilly’s Emgality and Mounjaro products. This research is based on a proprietary data set I collected over a 160+ week period from February 2021-April 2024. I am a chronic migraine patient and have been an analyst for 14 years. The data collection and analysis is my own. Within the data, two trends emerged. First, temporal trends related to the source and triggers of migraines. Second, the treatment effectiveness of Eli Lilly’s Emgality and Mounjaro products increased over time.